Overview
Gemer PR Tablets combine Glimepiride, a sulfonylurea that stimulates insulin release, and Metformin, a biguanide that reduces glucose production in the liver and improves insulin sensitivity. The prolonged-release (PR) formulation of Metformin ensures sustained blood sugar control throughout the day. This dual-action antidiabetic medication is prescribed for patients with type 2 diabetes mellitus who are unable to achieve optimal glycemic control with single-agent therapy.





